Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 236

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo

Open access
Yao, Hangping, Lu, Xiangyun, Chen, Qiong, Xu, Kaijin, Chen, Yu, Cheng, Minghui, Chen, Keda, Cheng, Linfang, Weng, Tianhao, Shi, Danrong, Liu, Fumin, Wu, Zhigang, Xie, Mingjie, Wu, Haibo, Jin, Changzhong, Zheng, Min, Wu, Nanping, Jiang, Chao, Li, Lanjuan · 2020 · Cell Discovery

Published version of a preprint

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally with more than 33 million patients diagnosed, taking more than a million lives. Abundant mutations were observed but the functional consequences of these mutations are largely unknown. We report the mutation spectrum, replication dynamics, and infectivity of 11 patient-derived viral isolates in diverse cell lines, including the human lung cancer cell line Calu-3. We observed 46 mutations, including 9 different mutations in the spike gene. Importantly, these viral isolates show significant and consistent variations in replication dynamics and infectivity in tested cell lines, up to a 1500-fold difference in viral titers at 24 h after infecting Calu-3 cells. Moreover, we show that the variations in viral titers among viral isolates are positively correlated with blood clotting function but inversely correlated with the amount of red blood cell and hemoglobin in patients. Therefore, we provide direct evidence that naturally occurring mutations in SARS-CoV-2 can substantially change its replication dynamics and infectivity in diverse human cell lines, with clinical implications in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41421-020-00226-1

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 30

  1. Guan, W. et al. Clinical characteristics of Coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020). · DOI · Paper page
  2. Bai, Y. et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 323, 1406–1407 (2020). · DOI · Paper page
  3. Hu, Z. et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci. China Life Sci. 63, 706–711 (2020). · DOI · Paper page
  4. Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell 182, 73–84 (2020). · DOI · Paper page
  5. Tortorici, M. A. & Veesler, D. Structural insights into coronavirus entry. Adv. Virus Res. 105, 93–116 (2019). · DOI · Paper page
  6. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). · DOI · Paper page
  7. Li, X. et al. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Sci. Adv. 6, eabb9153 (2020). · DOI · Paper page
  8. Huang, J. M., Jan, S. S., Wei, X., Wan, Y. & Ouyang, S. Evidence of the recombinant origin and ongoing mutations in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Preprint at https://doi.org/10.1101/2020.03.16.993816 (2020) · DOI
  9. Lokman, S. M. et al. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach. Infect. Genet. Evol. 84, 104389 (2020). · DOI
  10. Konno, Y. et al. SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Rep. 32, 108185 (2020). · DOI · Paper page
  11. Daniloski, Z., Guo, X. & Sanjana, N. E. The D614G mutation in SARS-CoV-2 spike increases transduction of multiple human cell types. Preprint at https://doi.org/10.1101/2020.06.14.151357 (2020) · DOI
  12. Capobianchi, M. R. et al. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin. Microbiol. Infect. 26, 954–956 (2020). · DOI
  13. Taiaroa, G. et al. Direct RNA sequencing and early evolution of SARS-CoV-2. Preprint at https://doi.org/10.1101/2020.03.05.976167 (2020) · DOI
  14. Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565–574 (2020). · DOI · Paper page
  15. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). · DOI · Paper page
  16. Forni, D., Cagliani, R., Clerici, M. & Sironi, M. Molecular evolution of human coronavirus genomes. Trends Microbiol. 25, 35–48 (2017). · DOI · Paper page
  17. Renzette, N., Pfeifer, S. P., Matuszewski, S., Kowalik, T. F. & Jensen, J. D. On the analysis of intrahost and interhost viral populations: human cytomegalovirus as a case study of pitfalls and expectations. J. Virol. 5, e01976–16 (2017).
  18. Tajima, F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123, 585–595 (1989). · DOI · Paper page
  19. Ou, J. et al. RBD mutations from circulating SARS-CoV-2 strains enhance the structure stability and infectivity of the spike protein. Preprint at https://doi.org/10.1101/2020.03.15.991844 (2020) · DOI
  20. Schneider, M. et al. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-Calpain. J. Virol. 86, 10112–10122 (2012). · DOI
  21. Zhang, L. et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. Preprint at https://doi.org/10.1101/2020.06.12.148726 (2020) · DOI
  22. Willyard, C. Coronavirus blood-clot mystery intensifies. Nature 581, 250 (2020). · DOI
  23. Paranjpe, I. et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J. Am. Coll. Cardiol. 76, 122–124 (2020). · DOI · Paper page
  24. Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 3, 493–497 (1938). · DOI · Paper page
  25. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 14, 1754–1760 (2009). · DOI · Paper page
  26. Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19, 455–477 (2012). · DOI · Paper page
  27. Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568–576 (2012). · DOI · Paper page
  28. Capella-Gutiérrez, S., Silla-Martínez, J. M. & Gabaldón, T. trimAl: a tool for automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics 25, 1972–1973 (2009). · DOI · Paper page
  29. Letunic, I. & Bork, P. Interactive tree of life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res. 39, W475–W478 (2011). · DOI · Paper page
  30. Kumar, S., Stecher, G. & Tamura, K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870–1874 (2016). · DOI · Paper page

Cited by

See all 236

Metadata

Authors
Yao, H., Lu, X., Chen, Q., Xu, K., Chen, Y., Cheng, M., Chen, K., Cheng, L., Weng, T., Shi, D., Liu, F., Wu, Z., Xie, M., Wu, H., Jin, C., Zheng, M., Wu, N., Jiang, C., & Li, L.
Venue
Cell Discovery
Published
2020-10-29
Volume
6
Issue
1
Pages
76-76
ISSN
2056-5968 (ISSN-L)
OpenAlex
W3094903671
Cited by
236
References
19
FWCI
6.79
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. https://app.cochat.ai/papers/10.1038/s41421-020-00226-1
The paper
Yao, H., Lu, X., Chen, Q., Xu, K., Chen, Y., Cheng, M., Chen, K., Cheng, L., Weng, T., Shi, D., Liu, F., Wu, Z., Xie, M., Wu, H., Jin, C., Zheng, M., Wu, N., Jiang, C., & Li, L. (2020). Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discovery. https://doi.org/10.1038/s41421-020-00226-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.